Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Q1 Stability Testing of Drug Substances and Drug Products: Draft Guidance for Industry

Q1 Stability Testing of Drug Substances and Drug Products: Draft Guidance for Industry

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

June 23, 2025

June 24, 2025

Center for Drug Evaluation and Research

f97d5bb6-a78c-45d5-be86-41bb6e6c13b2

Related Documents

Q3E Guideline for Extractables and Leachables

Guidance DocumentNovember 28, 2025Center for Drug Evaluation and Research
View Details →

E6(R3) Good Clinical Practice: Annex 2

Guidance DocumentDecember 30, 2024Center for Drug Evaluation and Research
View Details →

M11 Clinical Electronic Structured Harmonised Protocol

Guidance DocumentDecember 21, 2022Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.